BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Lone Star Bio

  Seisa Medical Closes $42.5MM Recapitalization and Acquisition Line

  The cash will be used to pay fees and expenses associated with the transaction, fund a dividend to shareholders and complete acquisitions.

  February 5, 2018

   · 

  2 min read
• Drug Development

  BeyondSpring Summarizes Key Messages From KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia

  The data was recently presented at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium.

  February 5, 2018

   · 

  8 min read
• Biotech Bay

  CareDx Leadership in cfDNA Highlighted at CEoT

  CareDx symposium and panel presentations will showcase AlloSure experience.

  February 5, 2018

   · 

  4 min read
• BioMidwest

  PolarityTE Provides Business Updates on Clinical Use of SkinTE: Regeneration of Full-Thickness Skin

  The first group of patients treated with SkinTE are currently at an interim stage of healing and regeneration.

  February 5, 2018

   · 

  7 min read
• Merial, Now Part of Boehringer Ingelheim, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK Oral Bordetella

  RECOMBITEK vaccines are manufactured by Merial. Merial is now a part of Boehringer Ingelheim.

  February 5, 2018

   · 

  3 min read
• BioCapital

  McKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in Minutes

  Once prepared for each day’s use, the Sysmex XW-100 allows health care professionals to provide patients with blood test results in as few as three minutes.

  February 5, 2018

   · 

  4 min read
• Chi-Med to Announce 2017 Final Results

  Chi-Med will be announcing its final results for the year ended December 31, 2017 on Monday, March 12, 2018 at 7:00 am Greenwich Mean Time.

  February 5, 2018

   · 

  1 min read
• Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons on 2 February 2018

  The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

  February 5, 2018

   · 

  1 min read
• Viveve Announces Expansion of CMRF Technology Platform into Stress Urinary Incontinence Market

  A pilot study was conducted in Calgary, Alberta and included 10 patients who underwent treatment with Viveve’s CMRF technology under a proprietary treatment protocol.

  February 5, 2018

   · 

  7 min read
• Biotech Beach

  New Focal Charge Compensation Mode for ZEISS Field Emission Scanning Electron Microscopes Improves Image Quality

  In collaboration with theNCMIR at the University of California San Diego, ZEISS releases a new Focal Charge Compensation module for block face imaging with ZEISS GeminiSEM and 3View from Gatan, Inc.

  February 5, 2018

   · 

  1 min read